Home-based exercise for middle-aged Chinese at diabetic risk: A randomized controlled trial

Preventive Medicine

Volumn 52, Issue 5, 2011, Pages 337-343

  Wu, Ying Tai ^a   Hwang, Chueh Lung ^a   Chen, Chiao Nan ^b   Chuang, Lee Ming ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Adiponectin; Home based exercise; Insulin resistance; Metabolic risk factors; Physical activity; Physical fitness

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN; INSULIN;

ADULT; ARTICLE; BEHAVIOR; BLOOD LEVEL; BODY MASS; CHINA; EXERCISE; FEMALE; FITNESS; FOLLOW UP; HOME BASED EXERCISE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE;

ADIPONECTIN; DIABETES MELLITUS; EXERCISE; FEMALE; HOME CARE SERVICES; HUMANS; MALE; MIDDLE AGED; PHYSICAL FITNESS; PROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR; SELF EFFICACY; TAIWAN;

EID: 79954604409     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2011.02.018     Document Type: Article

References (50)

1. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257:79-83.
2. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005, 96:939-949.
3. Bluher M., Bullen J.W., Lee J.H., et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J. Clin. Endocrinol. Metab. 2006, 91:2310-2316.
4. Bock B.C., Marcus B.H., Pinto B.M., et al. Maintenance of physical activity following an individualized motivationally tailored intervention. Ann. Behav. Med. 2001, 23:79-87.
5. Boudou P., Sobngwi E., Mauvais-Jarvis F., et al. Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur. J. Endocrinol. 2003, 149:421-424.
6. Brekke H.K., Lenner R.A., Taskinen M.R., et al. Lifestyle modification improves risk factors in type 2 diabetes relatives. Diab. Res. Clin. Pract. 2005, 68:18-28.
7. Burton B., Fallon E. Body Image Moderates Transtheoretical Model Constructs for Physical Activity 2009, S52.
8. Chen C.N., Chuang L.M., Wu Y.T. Clinical measures of physical fitness predict insulin resistance in people at risk for diabetes. Phys. Ther. 2008, 88:1355-1364.
9. Cnop M., Havel P.J., Utzschneider K.M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46:459-469.
10. Esposito K., Pontillo A., Di Palo C., et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003, 289:1799-1804.
11. Giannopoulou I., Fernhall B., Carhart R., et al. Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism 2005, 54:866-875.
12. Helmrich S.P., Ragland D.R., Paffenbarger R.S. Prevention of non-insulin-dependent diabetes mellitus with physical activity. Med. Sci. Sports Exerc. 1994, 26:824-830.
13. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1595-1599.
14. IDF Latest diabetes figures paint grim global picture Accessed December 13, 2010. http://www.idf.org/latest-diabetes-figures-paint-grim-global-picture.
15. Jurimae J., Kums T., Jurimae T. Plasma adiponectin concentration is associated with the average accelerometer daily steps counts in healthy elderly females. Eur. J. Appl. Physiol. 2010, 109:823-828.
16. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846.
17. Kell R.T., Bell G., Quinney A. Musculoskeletal fitness, health outcomes and quality of life. Sports Med. 2001, 31:863-873.
18. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004, 89:2548-2556.
19. Khaw K.T., Jakes R., Bingham S., et al. Work and leisure time physical activity assessed using a simple, pragmatic, validated questionnaire and incident cardiovascular disease and all-cause mortality in men and women: the European prospective investigation into cancer in Norfolk prospective population study. Int. J. Epidemiol. 2006, 35:1034-1043.
20. Kim S.M., Cho K.H., Park H.S. Relationship between plasma adiponectin levels and the metabolic syndrome among Korean people. Endocr. J. 2006, 53:247-254.
21. King H., Kriska A.M. Prevention of type II diabetes by physical training. Epidemiological considerations and study methods. Diab. Care 1992, 15:1794-1799.
22. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002, 346:393-403.
23. Kondo T., Kobayashi I., Murakami M. Effect of exercise on circulating adipokine levels in obese young women. Endocr. J. 2006, 53:189-195.
24. Lara-Castro C., Luo N., Wallace P., et al. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006, 55:249-259.
25. Li S., Shin H.J., Ding E.L., et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009, 302:179-188.
26. Marcus B.H., Selby V.C., Niaura R.S., et al. Self-efficacy and the stages of exercise behavior change. Res. Q. Exerc. Sport 1992, 63:60-66.
27. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
28. McAuley E., Courneya K.S., Rudolph D.L., et al. Enhancing exercise adherence in middle-aged males and females. Prev. Med. 1994, 23:498-506.
29. Monzillo L.U., Hamdy O., Horton E.S., et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes. Res. 2003, 11:1048-1054.
30. Nishida Y., et al. Psychological determinants of physical activity in Japanese female employees. J. Occup. Health 2003, 45:15-22.
31. Oberbach A., Tonjes A., Kloting N., et al. Effect of a 4week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur. J. Endocrinol. 2006, 154:577-585.
32. Oman R.F., King A.C. Predicting the adoption and maintenance of exercise participation using self-efficacy and previous exercise participation rates. Am. J. Health Promot. 1998, 12:154-161.
33. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
34. Pan X.R., Li G.W., Hu Y .Hc, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diab. Care 1997, 20:537-544.
35. Quinn L. Mechanisms in the development of type 2 diabetes mellitus. J. Cardiovasc. Nurs. 2002, 16:1-16.
36. Sattar N., Wannamethee S.G., Forouhi N.G. Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?. Diabetologia 2008, 51:926-940.
37. Simpson K.A., Singh M.A. Effects of exercise on adiponectin: a systematic review. Obesity (Silver Spring) 2008, 16:241-256.
38. Sirur R., Richardson J., Wishart L., et al. The role of theory in increasing adherence to prescribed practice. Physiother. Can. 2009, 61:68-77.
39. Stevens J., et al. The effect of age on the association between body-mass index and mortality. N. Engl. J. Med. 1998, 338:1-7.
40. Tjonna A.E., et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 2008, 118:346-354.
41. Trapp E.G., Chisholm D.J., Freund J., et al. The effects of high-intensity intermittent exercise training on fat loss and fasting insulin levels of young women. Int. J. Obes. (Lond.) 2008, 32:684-691.
42. Tsukinoki R., Morimoto K., Nakayama K. Association between lifestyle factors and plasma adiponectin levels in Japanese men. Lipids Health Dis. 2005, 4:27.
43. Tuomilehto J., Lindstrom J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 2001, 344:1343-1350.
44. Wang J., Li H., Franco O.H., et al. Adiponectin and metabolic syndrome in middle-aged and elderly Chinese. Obesity (Silver Spring) 2008, 16:172-178.
45. Wang T.D., Goto S., Bhatt D.L., et al. Ethnic differences in the relationships of anthropometric measures to metabolic risk factors in Asian patients at risk of atherothrombosis: results from the REduction of Atherothrombosis for Continued Health (REACH) Registry. Metabolism 2010, 59:400-408.
46. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diab. Care 2004, 27:1047-1053.
47. Willett W.C., Dietz W.H., Colditz G.A., et al. Guidelines for healthy weight. N. Engl. J. Med. 1999, 341:427-434.
48. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001, 7:941-946.
49. Yang W.S., Lee W.J., Funahashi T., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 2001, 86:3815-3819.
50. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787.